New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or ...
FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...
Please provide your email address to receive an email when new articles are posted on . Orthopedic surgeons are evaluated on patient experience through patient-focused surveys, patient-related outcome ...
Treatment with QP-6211 achieved primary and all key secondary endpoints in both placebo- and active-controlled Phase 3 trials following hemorrhoidectomy or bunionectomy. QP-6211 demonstrated ...
This transcript has been edited for clarity. Jeff Gadsden, MD: Hello, I'm Dr Jeff Gadsden, a professor of anesthesiology at Duke University Hospital in North Carolina. And with me is Dr Eliana ...
Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 After resection of T3-4, N0, M0 or T1-4, N1, 2M0 rectal adenocarcinoma, ...
SAN DIEGO, May 18, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class ...
SOUTHLAKE, Texas, Jan. 9, 2024 /PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic ...
Antibe Therapeutics, Inc. ATBPF ATE is developing otenaproxesul as a solution to the dose-related gastrointestinal (GI) side effects associated with non-steroidal anti-inflammatory drugs (NSAIDs). It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results